Xiamen Amoytop Biotech Co., Ltd. Class ASSE: 688278

Announcement on Voluntary Disclosure on the Acceptance Notification of Clinical Trial Application for ACT201 Injection

· Issued by Xiamen Amoytop Biotech Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure on the Acceptance Notification of Clinical Trial Application for ACT201 Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment